Clinical Trials Directory

Trials / Completed

CompletedNCT00485537

Pregnancy Outcomes With a GnRH Antagonist Protocol Versus GnRH-Agonist Protocol in ICSI Cycles

Pregnancy Outcomes With a Gonadotropin-Releasing Hormone (GnRH) Antagonist (Cetrorelix) Protocol Versus GnRH-Agonist Protocol in Ovarian Stimulation for ICSI Cycles-a Prospective Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2,005 (actual)
Sponsor
Clinic and Research Center in Human Reproduction Roger Abdelmassih · Academic / Other
Sex
Female
Age
22 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Cycles with GnRH agonist and GnRH antagonist were compared and main outcome measures were the number of oocytes retrieved, injected and fertilized, embryos transferred, and clinical pregnancy and miscarriage rates, were analized.

Detailed description

160 women were equally divided between a GnRH antagonist protocol (Group 1) versus a GnRH agonist protocol (Group 2) in ICSI cycles. The trial was conducted between September 2005 and December 2006. The mean age in both groups was 32 (range 22-40). The main outcome measures were the number of oocytes retrieved, injected and fertilized, embryos transferred, and clinical pregnancy and miscarriage rates.

Conditions

Interventions

TypeNameDescription
PROCEDUREoocyte retrieval and ICSI procedure

Timeline

Start date
2005-09-01
Completion
2006-12-01
First posted
2007-06-13
Last updated
2007-06-13

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00485537. Inclusion in this directory is not an endorsement.

Pregnancy Outcomes With a GnRH Antagonist Protocol Versus GnRH-Agonist Protocol in ICSI Cycles (NCT00485537) · Clinical Trials Directory